by support | Aug 12, 2025 | Blogs
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis August 12, 2025 marks a new chapter in care for patients worldwide Tuesday, August 12, 2025, is a monumental day for the bronchiectasis community. The U.S. Food and Drug Administration...
by support | Jul 21, 2025 | Blogs
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support Every year on August 4th, we come together to recognize World NTM Awareness Day, a global movement dedicated to raising awareness about nontuberculous mycobacterial (NTM) lung...
by support | Jul 21, 2025 | Blogs
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference Held May 14–15 in Berkeley, California and Online The 2025 NTM & Bronchiectasis Patient Conference brought together patients, caregivers, clinicians, and researchers...
by support | May 7, 2025 | Blogs
Supporting Mental Health for the NTM Community: Mental Health Awareness Month May is Mental Health Awareness Month, a time to shine a light on the importance of emotional well-being — especially for those living with chronic illnesses like NTM (nontuberculous...
by Rushali Dash | Apr 2, 2025 | Blogs
We’re excited to announce that registration is now open for the 2025 NTM & Bronchiectasis Patient Conference, hosted by NTM Info & Research (NTMir)! This year’s conference promises to be an invaluable experience for patients and caregivers seeking the latest...
by Rushali Dash | Mar 21, 2025 | Blogs
Bronchiectasis patients and caregivers are urged to share their stories as soon as possible! On March 11, the Institute for Clinical and Economic Review (ICER) announced a review of brensocatib for the treatment of non-cystic fibrosis bronchiectasis (NCFB)....
